Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.51 GBX -1.28% Market Closed
Market Cap: 76.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Creo Medical Group PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Creo Medical Group PLC
Cash & Cash Equivalents Peer Comparison

Comparables:
SN
LIVN
EKF
AGL
B
BELL

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Cash & Cash Equivalents
ÂŁ9.8m
CAGR 3-Years
-32%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Cash & Cash Equivalents
$568m
CAGR 3-Years
-26%
CAGR 5-Years
33%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Cash & Cash Equivalents
$346.4m
CAGR 3-Years
24%
CAGR 5-Years
36%
CAGR 10-Years
11%
EKF Diagnostics Holdings PLC
LSE:EKF
Cash & Cash Equivalents
ÂŁ9.8m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
-1%
Angle PLC
LSE:AGL
Cash & Cash Equivalents
ÂŁ17.9m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Belluscura PLC
LSE:BELL
Cash & Cash Equivalents
$2m
CAGR 3-Years
58%
CAGR 5-Years
31%
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
9.8m GBP

Based on the financial report for Jun 30, 2024, Creo Medical Group PLC's Cash & Cash Equivalents amounts to 9.8m GBP.

What is Creo Medical Group PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-24%

Over the last year, the Cash & Cash Equivalents growth was -15%. The average annual Cash & Cash Equivalents growth rates for Creo Medical Group PLC have been -32% over the past three years , -24% over the past five years .

Back to Top